⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8914655 | 0.81 | NPC1 (0.30) | — | |
| SCHEMBL361494 | 0.69 | — | — | |
| SCHEMBL439390 | 0.65 | MAPT (0.32) | — | |
| SCHEMBL13252205 | 0.65 | CHRM1 (0.32) | — | |
| SCHEMBL27879288 | 0.65 | — | — | |
| SCHEMBL7591208 | 0.64 | — | — | |
| SCHEMBL28282164 | 0.64 | CHRM1 (0.31) | — | |
| SCHEMBL7999505 | 0.61 | — | — | |
| SCHEMBL7569766 | 0.61 | — | — | |
| SCHEMBL420698 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2529007-A1 | TREATMENT OF BONE-RELATED CANCERS USING PLACENTAL STEM CELLS | Anthrogenesis Corporation (US) | 2012-12-05 | — | — | EP | disclosed |
| WO-2011094181-A1 | TREATMENT OF BONE-RELATED CANCERS USING PLACENTAL STEM CELLS | ANTHROGENESIS CORPORATION (US) | 2011-08-04 | — | — | WO | disclosed |